Program

■JCA-AACR Joint Symposia

* Sponsored by Princess Takamatsu Cancer Research Fund

1. Molecular targeted therapies for breast cancer

October 8 (Sat.)　9:00‐11:30

Chairpersons:	Yoshio Miki	Med. Res. Inst., Tokyo Med. & Dent. Univ.
	José Baselga	Memorial Sloan Kettering Cancer Ctr.

2. Personalized treatments based on cancer genome profile

October 7 (Fri.)　9:00‐11:30

Chairpersons:	Hiroyuki Mano	The Univ. of Tokyo /Natl. Cancer Ctr. Res. Inst.
	Marc Ladanyi	Memorial Sloan Kettering Cancer Ctr.

■Core Symposia

1. Interplay between tumor heterogeneity and tumor microenvironment

October 6 (Thu.)　9:00‐11:30

Chairpersons:	Hideyuki Saya	Inst. for Advanced Med. Res., Keio Univ. Sch. of Med.
	Naoya Fujita	Cancer Chemother. Ctr., Japanese Foundation for Cancer Res.

2. Beyond the immune checkpoint blockade

October 7 (Fri.)　12:50‐15:20

Chairpersons:	Yutaka Kawakami	Inst. for Advanced Med. Res., Keio Univ. Sch. of Med.
	Yasuharu Nishimura	Kumamoto Univ.

3. Context-dependent TGF-β signaling and tumor progression

October 7 (Fri.)　12:50‐15:20

Chairpersons:	Keiji Miyazawa	Univ. of Yamanashi
	Mitsuyasu Kato	Univ. of Tsukuba

4. Precision medicine: Genome and beyond

October 8 (Sat.)　14:40‐17:10

Chairpersons:	Katsuya Tsuchihara	Exploratory Oncology Res. & Clin. Trial Ctr., Natl. Cancer Ctr.
	Yoichi Furukawa	The Inst. of Med. Sci., The Univ. of Tokyo

■International Sessions

Session Details

1. Methods of integrative mathematical oncology

October 6 (Thu.)　9:00‐11:30

Chairpersons:	Takashi Suzuki	Osaka Univ.
	Yu Shyr	Cancer for Quantitive Sci., Vanderbilt Univ.

* Supported by Coop-Math Program by the MEXT

2. Wnt signaling as therapeutic targets

October 6 (Thu.)　9:00‐11:30

Chairpersons:	Noriko Goto	Cancer Res. Inst. of Kanazawa Univ.
	David M. Virshup	Duke-NUS Med. Sch.

3. Clinical sequencing with NGS panel for precision medicine

October 6 (Thu.)　12:50‐15:20

Chairpersons:	Atsushi Ohtsu	Exploratory Oncology Res. & Clin. Trial Ctr., Natl. Cancer Ctr.
	Patrick Tan	Duke-NUS Med. Sch.

4. Advances in Drug Delivery System (DDS)

October 6 (Thu.)　12:50‐15:20

Chairpersons:	Nobuhiro Nishiyama	Lab. for Chemistry & Life Sci. Inst. of Innovative Res., Tokyo Inst. of Tech.
	Won Jong Kim	Ctr. for Self-assembly and Complexity, IBS

5. Frontiers in genome engineering

October 7 (Fri.)　9:00‐11:30

Chairpersons:	Yasuhiro Yamada	Ctr. for iPS Cell Res. and Application, Kyoto Univ.
	Jin-Soo Kim	Ctr. for Genome Engineering, Inst. for Basic Sci.

6. Metabolic feature of cancers for anti-cancer therapy

October 7 (Fri.)　9:00‐11:30

Chairpersons:	Hozumi Motohashi	Inst. of Development, Aging & Cancer, Tohoku Univ.
	Young IL Yeom	Biotherapeutics Translational Res. Ctr., KRIBB

7. Liquid biopsy for cancer genome and precision medicine

October 7 (Fri.)　12:50‐15:20

Chairpersons:	Hidewaki Nakagawa	RIKEN IMS
	Frank Diehl	R&D, Sysmex

8. Non-coding RNA, a new epigenetic regulator in cancer

October 7 (Fri.)　12:50‐15:20

Chairpersons:	Hiromu Suzuki	Sapporo Med. Univ. Sch. of Med.
	Jong-Hoon Park	Dept. of Biological Sci., Sookmyung Women's Univ.

9. New era of cancer immunotherapy

October 8 (Sat.)　9:00‐11:30

Chairpersons:	Hiroyoshi Nishikawa	Exploratory Oncology Res. & Clin. Trial Ctr., Natl. Cancer Ctr.
	Belinda S. Parker	Dept. of Biochem. & Genetics, LIMS, La Trobe Univ.

10. Like a bridge over troubled water: Inviting social scientists into controversies of health policies

October 8 (Sat.)　9:00‐11:30

Chairpersons:	Yumiko Mochizuki	Ctr. for Cancer Control and Information Services, Natl. Cancer Ctr.
	Bruce Headey	Univ. of Melbourne

11. Tumor heterogeneity and clonal evolution: Focus on malignant brain tumors

October 8 (Sat.)　13:50‐16:20

Chairpersons:	Akitake Mukasa	The Univ. of Tokyo
	Do-Hyun Nam	Dept. of Neurosurgery, Samsung Med. Ctr.

12. Micro-environment of Asian common cancer

October 8 (Sat.)　13:50‐16:20

Chairpersons:	Haruhiko Sugimura	Hamamatsu Univ. Sch. of Med.
	Yang-Sook Chun	Dept. of Physiol., SNU

■Symposia

1. DNA damage response and repair in cancer

October 6 (Thu.)　9:00‐11:30

Chairpersons:	Makoto Nakanishi	The Inst. of Med. Sci., The Univ. of Tokyo
	Kozo Tanaka	Inst. of Development, Aging & Cancer, Tohoku Univ.

2. ncRNAs: A new paradigm in cancer pathogenesis, diagnosis and therapy

October 6 (Thu.)　9:00‐11:30

Chairpersons:	Johji Inazawa	Med. Res. Inst., Tokyo Med. & Dent. Univ.
	Tetsu Akiyama	Inst. of Mol. & Cell. Biosci., The Univ. of Tokyo

3. New frontiers of hereditary cancer towards the precision medicine

October 6 (Thu.)　9:00‐11:30

Chairpersons:	Yoshio Miki	Med. Res. Inst., Tokyo Med. & Dent. Univ.
	Yoshinori Murakami	The Inst. of Med. Sci., The Univ. of Tokyo

4. Epigenetic therapeutic targets: Discovery and utilization

October 6 (Thu.)　9:00‐11:30

Chairpersons:	Yutaka Kondo	Nagoya City Univ.
	Toshikazu Ushijima	Natl. Cancer Ctr. Res. Inst.

5. Development of the molecular-targeting drugs and their application to the clinical medicine

October 6 (Thu.)　12:50‐15:20

Chairpersons:	Koichi Hagiwara	Jichi Med. Univ.
	Minoru Yoshida	Chemical Genetics Lab., RIKEN

6. Key signal transduction pathways in cancer development

October 6 (Thu.)　12:50‐15:20

Chairpersons:	Jun-ichiro Inoue	The Inst. of Med. Sci., The Univ. of Tokyo
	Hidenori Ichijo	The Univ. of Tokyo

7. Targeting metabolism in cancer

October 6 (Thu.)　12:50‐15:20

Chairpersons:	Issay Kitabayashi	Natl. Cancer Ctr. Res. Inst.
	Chiaki Takahashi	Cancer Res. Inst. of Kanazawa Univ.

8. Basic aspects of cancer immunity

October 7 (Fri.)　9:00‐11:30

Chairpersons:	Shimon Sakaguchi	Osaka Univ.
	Koji Tamada	Yamaguchi Univ.

9. Biotherapy of cancer: New antibody therapeutics and oncolytic virus therapy

October 7 (Fri.)　9:00‐11:30

Chairpersons:	Yasuhiro Matsumura	Exploratory Oncology Res. & Clin. Trial Ctr., Natl. Cancer Ctr.
	Tomoki Todo	Advanced Clin. Res. Ctr., The Inst. of Med. Sci., The Univ. of Tokyo

10. Therapeutic vulnerability in infection/inflammation-associated cancer

October 7 (Fri.)　9:00‐11:30

Chairpersons:	Masanori Hatakeyama	The Univ. of Tokyo
	Masanobu Oshima	Cancer Res. Inst. of Kanazawa Univ.

11. New development of pathological diagnosis for personalized medicine

October 7 (Fri.)　12:50‐15:20

Chairpersons:	Wataru Yasui	Hiroshima Univ.
	Atsushi Ochiai	Natl. Cancer Ctr. Res. Inst.

12. Advances in cancer animal models: From mechanisms to clinical output

October 7 (Fri.)　12:50‐15:20

Chairpersons:	Takuro Nakamura	Japanese Foundation for Cancer Res.
	Akira Suzuki	Kobe Univ. Grad. Sch. of Med.

13. Development, senescence and cancer

October 7 (Fri.)　12:50‐15:20

Chairpersons:	Masahide Takahashi	Ctr. for Neurological Disease & Cancer, Nagoya Univ. Grad. Sch. of Med.
	Tatsushi Igaki	Kyoto Univ.

14. Lessons from large scale cancer genome data

October 8 (Sat.)　9:00‐11:30

Chairpersons:	Hiroyuki Aburatani	Res. Ctr. for Advanced Sci. & Tech., The Univ. of Tokyo
	Tatsuhiro Shibata	The Inst. of Med. Sci., The Univ. of Tokyo

15. Development and application of advanced imaging techniques for cancer

October 8 (Sat.)　9:00‐11:30

Chairpersons:	Takeshi Imamura	Ehime Univ.
	Yasuteru Urano	The Univ. of Tokyo

16. Cancer metastasis: Beyond EMT

October 8 (Sat.)　9:00‐11:30

Chairpersons:	Akira Kikuchi	Osaka Univ.
	Tetsuro Watabe	Tokyo Med. & Dent. Univ.

17. The intestinal microflora and cancer

October 8 (Sat.)　13:50‐16:20

Chairpersons:	Eiji Hara	Res. Inst. for Microbial Diseases, Osaka Univ.
	Toshiro Sato	Keio Univ. Sch. of Med.

18. Molecular basis of chromosome and genome instability in cancer

October 8 (Sat.)　13:50‐16:20

Chairpersons:	Fuyuki Ishikawa	Kyoto Univ.
	Kiyoshi Miyagawa	The Univ. of Tokyo

■Morning Lecture

22. Targeting TGF-β signaling in cancer

October 8 (Sat.) 8:00‐8:50

Chairpersons:	Shingo Maeda	Kagoshima Univ.
	Peter ten Dijke	Mol. Cell Biol., Leiden Univ. Med. Ctr.